Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

In Vivo Gene Essentiality and Metabolism in Bordetella pertussis.

Gonyar LA, Gelbach PE, McDuffie DG, Koeppel AF, Chen Q, Lee G, Temple LM, Stibitz S, Hewlett EL, Papin JA, Damron FH, Eby JC.

mSphere. 2019 May 22;4(3). pii: e00694-18. doi: 10.1128/mSphere.00694-18.

2.

Bordetella pertussis Can Be Motile and Express Flagellum-Like Structures.

Hoffman CL, Gonyar LA, Zacca F, Sisti F, Fernandez J, Wong T, Damron FH, Hewlett EL.

MBio. 2019 May 14;10(3). pii: e00787-19. doi: 10.1128/mBio.00787-19.

3.

Analysis of the In Vivo Transcriptome of Bordetella pertussis during Infection of Mice.

Wong TY, Hall JM, Nowak ES, Boehm DT, Gonyar LA, Hewlett EL, Eby JC, Barbier M, Damron FH.

mSphere. 2019 Apr 17;4(2). pii: e00154-19. doi: 10.1128/mSphereDirect.00154-19.

4.

Non-NAD-like PARP-1 inhibitors in prostate cancer treatment.

Karpova Y, Wu C, Divan A, McDonnell ME, Hewlett E, Makhov P, Gordon J, Ye M, Reitz AB, Childers WE, Skorski T, Kolenko V, Tulin AV.

Biochem Pharmacol. 2019 Mar 15. pii: S0006-2952(19)30107-8. doi: 10.1016/j.bcp.2019.03.021. [Epub ahead of print]

PMID:
30880062
5.

Non-NAD-like PARP1 inhibitor enhanced synthetic lethal effect of NAD-like PARP inhibitors against BRCA1-deficient leukemia.

Nieborowska-Skorska M, Maifrede S, Ye M, Toma M, Hewlett E, Gordon J, Le BV, Sliwinski T, Zhao H, Piwocka K, Valent P, Tulin AV, Childers W, Skorski T.

Leuk Lymphoma. 2019 Apr;60(4):1098-1101. doi: 10.1080/10428194.2018.1520988. Epub 2018 Oct 2. No abstract available.

PMID:
30277116
6.

Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.

Boehm DT, Hall JM, Wong TY, DiVenere AM, Sen-Kilic E, Bevere JR, Bradford SD, Blackwood CB, Elkins CM, DeRoos KA, Gray MC, Cooper CG, Varney ME, Maynard JA, Hewlett EL, Barbier M, Damron FH.

Infect Immun. 2018 Sep 21;86(10). pii: e00857-17. doi: 10.1128/IAI.00857-17. Print 2018 Oct.

7.

New genotypes of Liao ning virus (LNV) in Australia exhibit an insect-specific phenotype.

Prow NA, Mah MG, Deerain JM, Warrilow D, Colmant AMG, O'Brien CA, Harrison JJ, McLean BJ, Hewlett EK, Piyasena TBH, Hall-Mendelin S, van den Hurk AF, Watterson D, Huang B, Schulz BL, Webb CE, Johansen CA, Chow WK, Hobson-Peters J, Cazier C, Coffey LL, Faddy HM, Suhrbier A, Bielefeldt-Ohmann H, Hall RA.

J Gen Virol. 2018 Apr;99(4):596-609. doi: 10.1099/jgv.0.001038. Epub 2018 Mar 13.

PMID:
29533743
8.

Ross River virus in Australian blood donors: possible implications for blood transfusion safety.

Faddy HM, Tran TV, Hoad VC, Seed CR, Viennet E, Chan HT, Harley R, Hewlett E, Hall RA, Bielefeldt-Ohmann H, Flower RLP, Prow NA.

Transfusion. 2018 Feb;58(2):485-492. doi: 10.1111/trf.14472. Epub 2018 Jan 19.

PMID:
29350414
9.

Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin.

Gonyar LA, Gray MC, Christianson GJ, Mehrad B, Hewlett EL.

Infect Immun. 2017 May 23;85(6). pii: e00198-17. doi: 10.1128/IAI.00198-17. Print 2017 Jun.

10.

Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin.

Wang X, Stapleton JA, Klesmith JR, Hewlett EL, Whitehead TA, Maynard JA.

Biochemistry. 2017 Mar 7;56(9):1324-1336. doi: 10.1021/acs.biochem.6b01163. Epub 2017 Feb 23.

12.

Modulation of Pertussis and Adenylate Cyclase Toxins by Sigma Factor RpoE in Bordetella pertussis.

Barbier M, Boehm DT, Sen-Kilic E, Bonnin C, Pinheiro T, Hoffman C, Gray M, Hewlett E, Damron FH.

Infect Immun. 2016 Dec 29;85(1). pii: e00565-16. doi: 10.1128/IAI.00565-16. Print 2017 Jan.

13.

Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.

Hoffman C, Eby J, Gray M, Heath Damron F, Melvin J, Cotter P, Hewlett E.

Mol Microbiol. 2017 Jan;103(2):214-228. doi: 10.1111/mmi.13551. Epub 2016 Nov 3.

14.

Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.

Eby JC, Gray MC, Warfel JM, Merkel TJ, Hewlett EL.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00370-16. doi: 10.1128/CVI.00370-16. Print 2017 Jan.

15.

Sealants for Preventing and Arresting Pit-and-fissure Occlusal Caries in Primary and Permanent Molars.

Wright JT, Tampi MP, Graham L, Estrich C, Crall JJ, Fontana M, Gillette EJ, Nový BB, Dhar V, Donly K, Hewlett ER, Quinonez RB, Chaffin J, Crespin M, Iafolla T, Siegal MD, Carrasco-Labra A.

Pediatr Dent. 2016;38(4):282-308. Review. Erratum in: Pediatr Dent. 2017 Mar 15;39(2):100.

PMID:
27557916
16.

Evidence-based clinical practice guideline for the use of pit-and-fissure sealants: A report of the American Dental Association and the American Academy of Pediatric Dentistry.

Wright JT, Crall JJ, Fontana M, Gillette EJ, Nový BB, Dhar V, Donly K, Hewlett ER, Quinonez RB, Chaffin J, Crespin M, Iafolla T, Siegal MD, Tampi MP, Graham L, Estrich C, Carrasco-Labra A.

J Am Dent Assoc. 2016 Aug;147(8):672-682.e12. doi: 10.1016/j.adaj.2016.06.001.

PMID:
27470525
17.

Sealants for preventing and arresting pit-and-fissure occlusal caries in primary and permanent molars: A systematic review of randomized controlled trials-a report of the American Dental Association and the American Academy of Pediatric Dentistry.

Wright JT, Tampi MP, Graham L, Estrich C, Crall JJ, Fontana M, Gillette EJ, Nový BB, Dhar V, Donly K, Hewlett ER, Quinonez RB, Chaffin J, Crespin M, Iafolla T, Siegal MD, Carrasco-Labra A.

J Am Dent Assoc. 2016 Aug;147(8):631-645.e18. doi: 10.1016/j.adaj.2016.06.003. Review. Erratum in: J Am Dent Assoc. 2017 Apr;148(4):210.

PMID:
27470524
18.

Review of the neutrophil response to Bordetella pertussis infection.

Eby JC, Hoffman CL, Gonyar LA, Hewlett EL.

Pathog Dis. 2015 Dec;73(9):ftv081. doi: 10.1093/femspd/ftv081. Epub 2015 Oct 2. Review.

19.

The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.

Wang X, Gray MC, Hewlett EL, Maynard JA.

J Biol Chem. 2015 Sep 18;290(38):23025. doi: 10.1074/jbc.A114.585281. No abstract available.

20.

Whole-genome sequencing in outbreak analysis.

Gilchrist CA, Turner SD, Riley MF, Petri WA Jr, Hewlett EL.

Clin Microbiol Rev. 2015 Jul;28(3):541-63. doi: 10.1128/CMR.00075-13. Review.

21.

High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.

D'Auria KM, Bloom MJ, Reyes Y, Gray MC, van Opstal EJ, Papin JA, Hewlett EL.

BMC Microbiol. 2015 Feb 4;15:7. doi: 10.1186/s12866-015-0361-4.

22.
23.

Cyclic AMP-mediated suppression of neutrophil extracellular trap formation and apoptosis by the Bordetella pertussis adenylate cyclase toxin.

Eby JC, Gray MC, Hewlett EL.

Infect Immun. 2014 Dec;82(12):5256-69. doi: 10.1128/IAI.02487-14. Epub 2014 Oct 6.

24.

The Australian Public is Still Vulnerable to Emerging Virulent Strains of West Nile Virus.

Prow NA, Hewlett EK, Faddy HM, Coiacetto F, Wang W, Cox T, Hall RA, Bielefeldt-Ohmann H.

Front Public Health. 2014 Sep 17;2:146. doi: 10.3389/fpubh.2014.00146. eCollection 2014.

25.

Pertussis pathogenesis--what we know and what we don't know.

Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES.

J Infect Dis. 2014 Apr 1;209(7):982-5. doi: 10.1093/infdis/jit639. Review.

26.

Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size.

Masin J, Fiser R, Linhartova I, Osicka R, Bumba L, Hewlett EL, Benz R, Sebo P.

Infect Immun. 2013 Dec;81(12):4571-82. doi: 10.1128/IAI.00711-13. Epub 2013 Sep 30.

27.

In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.

D'Auria KM, Kolling GL, Donato GM, Warren CA, Gray MC, Hewlett EL, Papin JA.

Infect Immun. 2013 Oct;81(10):3814-24. doi: 10.1128/IAI.00869-13. Epub 2013 Jul 29.

28.

Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Eby JC, Gray MC, Warfel JM, Paddock CD, Jones TF, Day SR, Bowden J, Poulter MD, Donato GM, Merkel TJ, Hewlett EL.

Infect Immun. 2013 May;81(5):1390-8. doi: 10.1128/IAI.00110-13. Epub 2013 Feb 19.

29.

Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Henderson MW, Inatsuka CS, Sheets AJ, Williams CL, Benaron DJ, Donato GM, Gray MC, Hewlett EL, Cotter PA.

Infect Immun. 2012 Jun;80(6):2061-75. doi: 10.1128/IAI.00148-12. Epub 2012 Apr 2.

30.

A metabolic network approach for the identification and prioritization of antimicrobial drug targets.

Chavali AK, D'Auria KM, Hewlett EL, Pearson RD, Papin JA.

Trends Microbiol. 2012 Mar;20(3):113-23. doi: 10.1016/j.tim.2011.12.004. Epub 2012 Jan 31. Review.

31.

Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles.

Donato GM, Goldsmith CS, Paddock CD, Eby JC, Gray MC, Hewlett EL.

FEBS Lett. 2012 Feb 17;586(4):459-65. doi: 10.1016/j.febslet.2012.01.032. Epub 2012 Jan 28.

32.

Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control.

D'Auria KM, Donato GM, Gray MC, Kolling GL, Warren CA, Cave LM, Solga MD, Lannigan JA, Papin JA, Hewlett EL.

BMC Syst Biol. 2012 Jan 6;6:2. doi: 10.1186/1752-0509-6-2.

33.

Role of CD11b/CD18 in the process of intoxication by the adenylate cyclase toxin of Bordetella pertussis.

Eby JC, Gray MC, Mangan AR, Donato GM, Hewlett EL.

Infect Immun. 2012 Feb;80(2):850-9. doi: 10.1128/IAI.05979-11. Epub 2011 Dec 5.

34.

Cell cycle arrest induced by the bacterial adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis.

Gray MC, Hewlett EL.

Cell Microbiol. 2011 Jan;13(1):123-34. doi: 10.1111/j.1462-5822.2010.01525.x. Epub 2010 Oct 14.

35.

Selective translocation of the Bordetella pertussis adenylate cyclase toxin across the basolateral membranes of polarized epithelial cells.

Eby JC, Ciesla WP, Hamman W, Donato GM, Pickles RJ, Hewlett EL, Lencer WI.

J Biol Chem. 2010 Apr 2;285(14):10662-70. doi: 10.1074/jbc.M109.089219. Epub 2010 Feb 5.

36.

The Pipeline program at The Ohio State University College of Dentistry: Oral Health Improvement through Outreach (OHIO) Project.

Thind A, Hewlett ER, Andersen RM, Bean CY.

J Dent Educ. 2009 Feb;73(2 Suppl):S96-106; discussion S106-7. No abstract available.

37.

The Pipeline program at Howard University College of Dentistry.

Andersen RM, Atchison KA, Hewlett ER, Grant-Mills D.

J Dent Educ. 2009 Feb;73(2 Suppl):S70-81; discussion S81-2. No abstract available.

38.

The Pipeline program at Boston University Goldman School of Dental Medicine.

Crall JJ, Hewlett ER, Friedman JA, Mascarenhas AK, Freilich S, Henshaw M, Jones JA, Mann M, Frankl S.

J Dent Educ. 2009 Feb;73(2 Suppl):S58-68; discussion S68-9. No abstract available.

39.

Summary and implications of the Dental Pipeline program evaluation.

Andersen RM, Davidson PL, Atchison KA, Crall JJ, Friedman JA, Hewlett ER, Thind A.

J Dent Educ. 2009 Feb;73(2 Suppl):S319-30. No abstract available.

40.

Revisions to dental school curricula: effects of the Pipeline program.

Hewlett ER, Davidson PL, Nakazono TT, Carreon DC, Gutierrez JJ, Afifi A.

J Dent Educ. 2009 Feb;73(2 Suppl):S259-68. No abstract available.

41.

The Pipeline program at the University of California, San Francisco, School of Dentistry.

Hewlett ER, Andersen RM, Atchison KA, Bird W.

J Dent Educ. 2009 Feb;73(2 Suppl):S199-209; discussion 210. No abstract available.

42.

The Pipeline program at West VIrginia University School of Dentistry.

Friedman JA, Hewlett ER, Atchison KA, Price SS.

J Dent Educ. 2009 Feb;73(2 Suppl):S161-72; discussion S173-4. No abstract available.

43.

The Pipeline program at the University of North Carolina at Chapel Hill School of Dentistry.

Hewlett ER, Andersen RM, Atchison KA, Strauss RP.

J Dent Educ. 2009 Feb;73(2 Suppl):S135-45; discussion S145-7. No abstract available.

44.

The Pipeline program at the University of Illinois at Chicago College of Dentistry.

Atchison KA, Hewlett ER, Friedman JA, Evans CA, Bolden AJ, Hryhorczuk C.

J Dent Educ. 2009 Feb;73(2 Suppl):S120-132; discussion S132-4. No abstract available.

45.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von König CH, Han L, Hueston L, Robbins JB, Powell M, Mink CM, Poolman JT, Hildreth SW, Lynn F, Morris A.

Vaccine. 2009 Feb 5;27(6):803-14. doi: 10.1016/j.vaccine.2008.11.072. Epub 2008 Dec 9.

PMID:
19071179
46.
47.

Etiology and management of whitening-induced tooth hypersensitivity.

Hewlett ER.

J Calif Dent Assoc. 2007 Jul;35(7):499-506. Review.

PMID:
17915592
48.

Effect of school environment on dental students' perceptions of cultural competency curricula and preparedness to care for diverse populations.

Hewlett ER, Davidson PL, Nakazono TT, Baumeister SE, Carreon DC, Freed JR.

J Dent Educ. 2007 Jun;71(6):810-8.

49.

Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis.

Tessier J, Green C, Padgett D, Zhao W, Schwartz L, Hughes M, Hewlett E.

Infect Immun. 2007 Apr;75(4):1895-903. Epub 2007 Jan 29.

50.

A fully integrated microfluidic genetic analysis system with sample-in-answer-out capability.

Easley CJ, Karlinsey JM, Bienvenue JM, Legendre LA, Roper MG, Feldman SH, Hughes MA, Hewlett EL, Merkel TJ, Ferrance JP, Landers JP.

Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19272-7. Epub 2006 Dec 11.

Supplemental Content

Loading ...
Support Center